Product nameNative Human HDL protein
See all HDL proteins and peptides
Purity> 95 % SDS-PAGE.
>95% of total lipoprotein content by electrophoresis.
Single arc by IEP against antisera to whole human serum.
Essentially free from other plasma lipoproteins as determined by electrophoresis using Fat Red 7B staining for lipids and Coomassie Blue for proteins.
Product is 0.2µm filtered.
Protein lengthFull length protein
Our Abpromise guarantee covers the use of ab77897 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Additional notesAll human source materials have tested non-reactive for anti-HBc, anti-HCV and HBsAg and negative for anti-HIV1 and HIV2 by FDA required tests. No test guarantees a product to be non-infectious.
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Store at +4°C. Do Not Freeze.
Constituents: 0.01% EDTA, 0.87% Sodium chloride
- High Density Lipoprotein
High-density lipoprotein (HDL) is one of the five major groups of lipoproteins, which, in order of sizes, largest to smallest, are chylomicrons, VLDL, IDL, LDL, and HDL, which enable lipids like cholesterol and triglycerides to be transported within the water-based bloodstream. In healthy individuals, about thirty percent of blood cholesterol is carried by HDL.
Blood tests typically report HDL-C level, i.e. the amount of cholesterol contained in HDL particles. It is often contrasted with low-density or LDL cholesterol or LDL-C. HDL particles are able to remove cholesterol from within artery atheroma and transport it back to the liver for excretion or re-utilization, which is the main reason why the cholesterol carried within HDL particles (HDL-C) is sometimes called "good cholesterol" (despite the fact that it is exactly the same as the cholesterol in LDL particles).
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab77897 has been referenced in 1 publication.
- Hayek SS et al. A tripartite complex of suPAR, APOL1 risk variants and avß3 integrin on podocytes mediates chronic kidney disease. Nat Med 23:945-953 (2017). PubMed: 28650456